Skip to main content
SURMODICS INC logo

SURMODICS INC — Investor Relations & Filings

Ticker · SRDX ISIN · US8688731004 LEI · 549300H76KXCAAGUS878 US Manufacturing
Open in API
Filings indexed 1,062 across all filing types
Latest filing 2013-11-20 Director's Dealing
Country US United States of America
Listing US SRDX

About SURMODICS INC

https://www.surmodics.com/

Surmodics, Inc. provides performance-enhancing technologies for the healthcare industry, focusing on medical devices and in vitro diagnostics. The company is a leading provider of surface modification technologies, offering customized hydrophilic, hemocompatible, and drug-delivery coatings for intravascular medical devices. In addition to its coatings business, Surmodics develops and commercializes a portfolio of vascular intervention medical devices for the treatment of peripheral arterial and venous disease, including thrombectomy and radial access platforms. The company also offers end-to-end contract development and manufacturing services. Its In Vitro Diagnostics (IVD) division supplies critical chemical components for immunoassays and microarrays, aiming to enhance the sensitivity and reproducibility of diagnostic tests.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2013-11-20 English
SURMODICS, INC. 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on material events. The content describes the entry into a material definitive agreement, specifically a $20 million secured revolving line of credit with Wells Fargo Bank. It details the terms of the credit agreement, interest rates, covenants, and other related financial obligations. There is also mention of a press release about quarterly and fiscal year results, but the main focus is the credit agreement. This type of filing is an update on the company's financing activities and capital structure, which fits the definition of a Capital/Financing Update (CAP). The document length is over 6,000 characters and contains substantive details about the financing arrangement, not just an announcement or summary, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA). Therefore, the correct classification is CAP with high confidence.
2013-11-05 English
SURMODICS, INC. 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated September 16, 2013. The key content is under Item 5.02, which discusses the departure of a director (Robert C. Buhrmaster) and the election of a new chairman (Scott R. Ward). This is a clear announcement of changes in the company's board of directors. There are no financial statements or detailed financial data present, and the document is relatively short (2925 characters). The primary focus is on management/board changes, which fits the Board/Management Information category. Therefore, the correct classification is MANG (Board/Management Information).
2013-09-20 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated September 3, 2013. It announces organizational changes including executive leadership responsibility changes and workforce realignment, with related financial impacts such as a one-time pre-tax charge and expected savings. The document includes a press release as an exhibit. There are no detailed financial statements or comprehensive financial data presented, only a summary of the event and its expected financial impact. The document is relatively short (4597 characters) and serves as an announcement of corporate changes and related costs rather than a full financial report or earnings release. This fits the category of a Regulatory Filing (RNS), which is a general regulatory announcement that does not fit into more specific categories like Annual Report, Earnings Release, or Management Reports.
2013-09-09 English
FORM 10-Q
Interim / Quarterly Report Q3 2013
2013-08-02 English
8-K Filing
Regulatory Filings Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated July 30, 2013, by SurModics, Inc. It reports the entry into a material definitive agreement, specifically a settlement and release agreement resolving litigation related to indemnification rights under a stock purchase agreement. The content focuses on legal settlement details and does not contain financial statements or performance data. It is not an annual or quarterly report, earnings release, or any other financial report type. The document is a regulatory filing reporting a material event as required by the SEC. Therefore, the appropriate classification is Regulatory Filings (RNS).
2013-08-02 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.